Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Eisai Wins Post-Operative Indication For Antiemetic Aloxi

Mar 03 2008

Related Content

Eisai Strengthens Oncology Position With $3.9 Billion MGI Pharma Acquisition

Dec 10 2007

MGI/Helsinn’s Aloxi Adds Multi-Day Dosing To Label

Sep 04 2007

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window